Blockchain: A Game-Changer for Pharma Supply Chains

Supply chain management in healthcare is highly complex, and recent health crises like COVID-19 have revealed many inconsistencies. There are many factors in place, like time and temperature sensitivity in drugs during shipping, inefficient maintenance of supply and demand, and a vast black market of counterfeit drugs.

Blockchain in the pharmaceutical supply chain can help solve many of those issues by providing secure, transparent tracking and verification at every stage. In this article, we look at the potential of blockchain in pharma for dealing with counterfeit, improving the efficiency of the supply chain, and ensuring cold chain management and regulatory compliance.

Ensuring drug authenticity with blockchain technology

One of the critical functions of blockchain in the drug supply chain is to prevent counterfeiting and make sure that counterfeited drugs do not reach the end users.

Based on the stats about drug development with real-world data , around 10-30% of drugs in low- and middle-income countries are counterfeit, leading to approximately 1 million deaths annually because they fail to treat and prevent diseases due to not being effective.

Blockchain in pharmacy prevents counterfeit because it makes drugs more visible. Here is how blockchain in pharma helps with drug traceability:

• Digital Ledger Technology (DLT) is used to verify the drug's authenticity at every step.
• Each drug batch or unit receives a unique identifier (e.g., QR code or serial number). This identifier is recorded on the ledger with information about the drug's origin, production date, and batch details.
• As the drug moves from the manufacturer to each point in the supply chain (e.g., supplier, distributor, pharmacy), its status and handling conditions are logged in real-time on the blockchain. Each entry is timestamped and cannot be altered.
• Authorized stakeholders (manufacturers, distributors, regulators, pharmacies) access the ledger to verify each drug's history. For example, a pharmacy can check the drug's origin, ensuring it's genuine before dispensing it to patients.
• Blockchain's transparency allows for an easy-to-follow audit trail, making regulatory audits and inspections quicker and simpler. The record of all transactions makes audit faster.
• Smart contracts automate compliance by verifying each step in the supply chain. For example, if a drug must be stored at a specific temperature, smart contracts can halt the distribution if conditions aren't met, preventing non-compliant drugs from reaching consumers.
• Some limited details of drug history may be available to the customer via QR code to ensure the product is authentic.
• Decentralized apps may be used to enhance traceability further. The way it can be done is a digital twin to a drug can be created. This helps all stakeholders monitor and analyze each medication's lifecycle in real time.

Improving supply chain visibility with blockchain

Blockchain enhances supply chain visibility by creating a transparent, secure ledger that records each transaction or transfer of drugs in real time. This enables all stakeholders to track the movement of drugs from production to the point of sale. Here's how it works:

Unique digital IDs for products

Each batch of drugs is assigned a unique digital ID, which is stored in the blockchain. This ID includes details like:

• Batch number
• Manufacturer details
• Production date and expiration date

Example: A pharmaceutical company manufactures a batch of vaccines, assigning it a unique ID. When the batch leaves the production facility, its details are entered into the blockchain ledger and visible to authorized supply chain participants.

Data entry at every stage

The blockchain updates the drug's status and location information at each stage—production, packaging, warehousing, and distribution.

Example: After production, the batch is transported to a warehouse, where it is scanned, and its status (like temperature during transport or storage conditions) is recorded on the blockchain. This information ensures that the product remains safe and within regulatory standards.

Use of smart contracts for compliance and automation

Smart contracts automatically enforce and record compliance rules. For instance, if a batch requires an expiration date, the blockchain smart contract verifies that the drugs remain within their allowable usage date throughout transit. If the batch approaches or exceeds its expiration date, the smart contract logs the deviation and can automatically block further movement of the expired batch.

Example: A batch of Doxorubicin, a chemotherapy drug with a strict expiration date, has this information encoded into a smart contract that continuously verifies the drug remains within its allowable usage date as it moves through the supply chain.

If the batch approaches expiration, the smart contract notifies stakeholders to prioritize its dispatch; if it expires, the contract flags and blocks it from further distribution. This automated process is recorded on the blockchain.

Access for all authorized stakeholders

Each participant—manufacturer to end-user—can access updated information and verify the product's journey. This transparency reduces the risk of counterfeiting and ensures all parties can validate the origin and path of the drug.

Example: A pharmacist scans a drug's QR code, accessing the blockchain to view its complete journey from production to pharmacy. This helps them verify authenticity before dispensing it to a patient.

Benefits of blockchain for pharma

• One obvious benefit of blockchain for karma is its decentralized structure. The framework eliminates the need for third-party intermediaries (such as pharmacies or hospitals) by using a decentralized ledger to record every transaction.
• Blockchain for the pharma supply chain increases transparency. It creates a visible, verifiable, and immutable record for each drug.
• Blockchain enhances control over the supply chain. Real-time tracking allows manufacturers and distributors to monitor and manage supply chain processes. This improves many components, including inventory management, delivery time, and different bottlenecks.
• In a pharmaceutical supply chain blockchain, customer refunds can be initiated automatically. If a breach is detected, the smart contract verifies the issue against pre-set thresholds and triggers the refund process for affected stakeholders, such as pharmacies or distributors. Breaches depend on what is specified in the contract, be it package integrity, temperature, expiration date, specific handlers, or else.
• Blockchain in the pharma supply chain saves costs. This is due to shared blockchain infrastructure and reduced administrative costs. Fewer resources are spent on a simplified supply chain.
• Blockchain for pharma simplifies regulatory compliance by providing accurate, real-time data for audits and inspections. This reduces the friction and costs associated with manual reporting and makes regulatory data accessible to stakeholders immediately.

Blockchain and cold chain management: a perfect match

A large number of meds are sensitive to meds and require cold-chain shipping. IBM estimates the annual total cost of products lost to temperature deviations during shipping is $35 billion, and every fourth vaccine that reaches the destination is degraded because of incorrect shipping (Source ).

Integrating blockchain with cold chain management systems is ideal for managing and safeguarding temperature-sensitive pharmaceuticals, such as vaccines and insulin. As a result, the quality of meds is maintained on their journey towards the end user. Here is how it works:

• IoT sensors attached to pharmaceuticals continuously monitor the temperature, humidity, and other critical factors. This data is automatically logged on the blockchain.
• Blockchain-integrated smart contracts automatically alert relevant stakeholders if temperature-sensitive drugs fall outside the required range. This allows for prompt action to prevent product spoilage.
• Let's say a shipment of vaccines requires a strict temperature range of 2–8°C. IoT sensors monitor the temperature every hour and log it on the blockchain. If a sensor detects a temperature excursion (e.g., 10°C), a smart contract triggers an alert, notifying the distributor and enabling quick intervention.
• Right before administering, a pharmacist checks a vaccine's QR code and accesses the blockchain record that verifies the product maintained safe conditions throughout distribution, ensuring it is safe to administer.
• Smart contracts enforce quality control standards by monitoring real-time data and automatically taking action if a parameter is breached. They can trigger automated notifications or halt further distribution if conditions compromise.
• For example, a shipment of insulin has a smart contract programmed to halt distribution if temperatures rise above a specific threshold. Upon detecting such a breach, the smart contract automatically pauses shipment, protecting patients from receiving compromised medication.

Smart contracts and pharma supply chains

Blockchain in pharma uses smart contracts to automatically initiate checks and flag suspicious batches. A smart contract is a self-executing contract that has predefined rules. The system automatically initiates certain actions when certain conditions are met or not met.

Basically, a smart contract is an instrument that causes the supply chain to move forward as long as everything is OK with the drug or halts it in case something happens, like when cold chain management fails. They track each step of the supply chain process. If stakeholders need to take action, a smart contract generates the alert.

• Smart contracts can track inventory levels in real time and automatically trigger orders when the stock falls below a set threshold.
• When a distributor places an order, a smart contract can verify that all terms are met (such as production completion and shipment initiation) and automatically release payment upon successful delivery.
• Smart contracts can automate supplier verifications, ensuring only authorized suppliers are involved in the supply chain.
• In cases of a recall, a smart contract can automatically identify all affected batches and trigger alerts to all entities within the supply chain.
• Smart contracts enable conditional payments, automatically releasing funds once pre-agreed terms are met. Third-party intermediaries are no longer expected to be involved.

Regulatory compliance and blockchain

Blockchain in the pharmaceutical supply chain can significantly aid pharmaceutical companies in adhering to regulatory requirements while ensuring patient safety.

Its transparency, security, and immutability make it a powerful tool for compliance with strict regulations, such as Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and the Drug Supply Chain Security Act (DSCSA) in the United States. Here's how:

Immutable record-keeping

• Benefit: Blockchain's ledger creates a permanent, unalterable record of every transaction in the supply chain, from production to distribution. This is vital for ensuring that data cannot be tampered with.
• Example: The US FDA conducted a pilot program in 2020 in collaboration with companies like IBM and KPMG to explore blockchain for secure drug traceability under the DSCSA. This pilot showed blockchain's potential to streamline compliance. The research revealed that the product's status can be verified in under a few seconds instead of the three days it took to verify compliance without blockchain for the pharmacy (Source ).

Data privacy and security for patient safety

• Benefit: Blockchain's permissioned networks protect sensitive patient and product information, limiting data access to only authorized parties. This security feature supports compliance with data privacy laws such as HIPAA and GDPR.
• Example: In 2019, Boehringer Ingelheim collaborated with IBM to implement a blockchain-based clinical supply management system. This system enhances data integrity and security during data analysis in clinical research by ensuring that only authorized parties can access sensitive patient information, supporting compliance with data privacy regulations like HIPAA and GDPR (Source ).

Overcoming challenges in implementing blockchain in pharma

While blockchain for pharmaceutical supply chains simplifies many processes and makes them more efficient, it can be not easy to implement blockchain due to many pre-existing challenges with the supply chain. Here are the major issues for pharma blockchain solutions:

Data privacy

Ensuring blockchain solutions comply with data privacy laws (such as GDPR and HIPAA) is critical but challenging due to blockchain's open and transparent nature.

Blockchain's unchangeable nature means that it cannot be altered or deleted once data is recorded. However, GDPR requires the "right to be forgotten," and individuals can request that their personal data be erased. Meeting this requirement is difficult on a blockchain where data is permanently stored.

To address these issues, solutions like permissioned blockchains (restricting access), off-chain data storage (storing sensitive data outside the blockchain), and zero-knowledge proofs (verifying data without revealing it) are being developed, but achieving full compliance remains technically and legally challenging.

Integration with existing systems

Pharmaceutical companies often rely on legacy systems and extensive infrastructure, making it difficult to integrate blockchain solutions seamlessly without disrupting operations. Gradual, hybrid integration strategies allow companies to introduce blockchain for pharmacy in phases, running blockchain systems alongside legacy systems to ease the transition.

Interoperability solutions like APIs or middleware can bridge blockchain with current systems. The pharmaceutical industry's view of blockchain should change for a more mainstream integration.

High implementation costs and resource demands

Transforming your supply chain in the pharma industry using blockchain is really expensive, especially for smaller healthcare companies.

Collaborative Consortia models, such as MediLedger and PharmaLedger, allow companies to share the costs and resources associated with blockchain development. By joining these consortiums, you do not have to build all the infrastructure from scratch.

Another way to deal with that is by working with third-party IT vendors with experience in blockchain, such as Binariks. We can:

• Implement blockchain infrastructure
• Ensure data privacy compliance (GDPR, HIPAA)
• Develop custom smart contracts
• Integrate IoT devices for real-time monitoring
• Provide interoperability solutions
• Offer data management and storage solutions
• Manage blockchain network maintenance
• Conduct regulatory compliance assessments

We are experienced with multiple facets of blockchain, including building decentralized apps that can act as a digital twin of a specific drug. We also build asset tokenization platforms, Decentralized Autonomous Organizations (DAOs), and ZKP (Zero Knowledge Proof) Chains that ensure privacy.

Final thoughts

To conclude, blockchain is poised to reshape drug tracking and delivery in pharma, bringing more transparency and security to the supply chain. Soon, it could make real-time monitoring and instant compliance checks a standard, cutting down on counterfeits and ensuring safe delivery to patients.

With increased adoption, pharma blockchain solutions could become the backbone for trusted, global healthcare networks, connecting manufacturers, distributors, and regulators like never before. Digital transformation in pharma is impossible without blockchain, as the efficiency of the supply chain matters a lot.